Logo for Adicet Bio Inc

Adicet Bio Investor Relations Material

Latest events

Logo for Adicet Bio Inc

Status Update

Adicet Bio
Logo for Adicet Bio

Q1 2024

14 May, 2024
Logo for Adicet Bio

Q4 2023

19 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Adicet Bio Inc

Access all reports
Adicet Bio Inc. is a clinical-stage biotechnology company focused on the discovery and development of allogeneic gamma delta T cell therapies for cancer and other diseases. The company specializes in creating off-the-shelf genetically modified gamma delta T cells that selectively target tumors, leveraging the unique properties of these cells to offer a new generation of immune cell therapy. The company is headquartered in Redwood City, California, and its shares are listed on the Nasdaq.